Galectin Therapeutics
GALT
#8191
Rank
C$0.23 B
Marketcap
$3.81
Share price
-3.37%
Change (1 day)
42.44%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2024 (TTM): -C$59.93 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$57.46 Million a decrease over its 2022 earnings that were of -C$54.26 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$59.93 Million4.31%
2023 -C$57.46 Million5.91%
2022 -C$54.26 Million27.02%
2021 -C$42.72 Million30.1%
2020 -C$32.84 Million76.51%
2019 -C$18.6 Million-4.36%
2018 -C$19.45 Million-14.38%
2017 -C$22.72 Million-24.26%
2016 -C$30 Million7.04%
2015 -C$28.02 Million26.85%
2014 -C$22.09 Million30.61%
2013 -C$16.92 Million27.82%
2012 -C$13.24 Million-9.15%
2011 -C$14.57 Million113.17%
2010 -C$6.84 Million-19.86%
2009 -C$8.53 Million14.4%
2008 -C$7.46 Million-17.49%
2007 -C$9.04 Million-8.41%
2006 -C$9.87 Million5.91%
2005 -C$9.32 Million-8.89%
2004 -C$10.22 Million47.92%
2003 -C$6.91 Million50.22%
2002 -C$4.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$1.08 Billion 1,627.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.42 M-131.36%๐Ÿ‡บ๐Ÿ‡ธ USA